Altimmune (FRA:3G0) FFO


FRA:3G0 Altimmune Inc FRA:3G0
28 GF Score
Price €2.42
! 2 Warning Signs
View Full Analysis

What is Altimmune FFO?

FFO (Funds from operations) only applies to REITs.

FRA:3G0
28GF Score
Altimmune Inc FRA:3G0
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Altimmune Business Description

Address 910 Clopper Road, Suite 201S, Gaithersburg, MD, USA, 20878
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
28GF Score

Get the complete analysis for FRA:3G0

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.42
Price